Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]

Detalles Bibliográficos
Autores principales: Choueiri, T.K., Larkin, J., Pal, S., Motzer, R.J., Rini, B.I., Venugopal, B., Alekseev, B., Miyake, H., Gravis, G., Bilen, M.A., Hariharan, S., Chudnovsky, A., Ching, K.A., Mu, X.J., Mariani, M., Robbins, P.B., Huang, B., di Pietro, A., Albiges, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411062/
https://www.ncbi.nlm.nih.gov/pubmed/34474809
http://dx.doi.org/10.1016/j.esmoop.2021.100177
_version_ 1783747228202958848
author Choueiri, T.K.
Larkin, J.
Pal, S.
Motzer, R.J.
Rini, B.I.
Venugopal, B.
Alekseev, B.
Miyake, H.
Gravis, G.
Bilen, M.A.
Hariharan, S.
Chudnovsky, A.
Ching, K.A.
Mu, X.J.
Mariani, M.
Robbins, P.B.
Huang, B.
di Pietro, A.
Albiges, L.
author_facet Choueiri, T.K.
Larkin, J.
Pal, S.
Motzer, R.J.
Rini, B.I.
Venugopal, B.
Alekseev, B.
Miyake, H.
Gravis, G.
Bilen, M.A.
Hariharan, S.
Chudnovsky, A.
Ching, K.A.
Mu, X.J.
Mariani, M.
Robbins, P.B.
Huang, B.
di Pietro, A.
Albiges, L.
author_sort Choueiri, T.K.
collection PubMed
description
format Online
Article
Text
id pubmed-8411062
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84110622021-09-08 Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] Choueiri, T.K. Larkin, J. Pal, S. Motzer, R.J. Rini, B.I. Venugopal, B. Alekseev, B. Miyake, H. Gravis, G. Bilen, M.A. Hariharan, S. Chudnovsky, A. Ching, K.A. Mu, X.J. Mariani, M. Robbins, P.B. Huang, B. di Pietro, A. Albiges, L. ESMO Open Erratum Elsevier 2021-06-08 /pmc/articles/PMC8411062/ /pubmed/34474809 http://dx.doi.org/10.1016/j.esmoop.2021.100177 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Erratum
Choueiri, T.K.
Larkin, J.
Pal, S.
Motzer, R.J.
Rini, B.I.
Venugopal, B.
Alekseev, B.
Miyake, H.
Gravis, G.
Bilen, M.A.
Hariharan, S.
Chudnovsky, A.
Ching, K.A.
Mu, X.J.
Mariani, M.
Robbins, P.B.
Huang, B.
di Pietro, A.
Albiges, L.
Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]
title Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]
title_full Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]
title_fullStr Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]
title_full_unstemmed Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]
title_short Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101]
title_sort erratum to ‘efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [esmo open volume 6, issue 3, june 2021, 100101]
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8411062/
https://www.ncbi.nlm.nih.gov/pubmed/34474809
http://dx.doi.org/10.1016/j.esmoop.2021.100177
work_keys_str_mv AT choueiritk erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT larkinj erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT pals erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT motzerrj erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT rinibi erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT venugopalb erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT alekseevb erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT miyakeh erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT gravisg erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT bilenma erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT hariharans erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT chudnovskya erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT chingka erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT muxj erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT marianim erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT robbinspb erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT huangb erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT dipietroa erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101
AT albigesl erratumtoefficacyandcorrelativeanalysesofavelumabplusaxitinibversussunitinibinsarcomatoidrenalcellcarcinomaposthocanalysisofarandomizedclinicaltrialesmoopenvolume6issue3june2021100101

Ejemplares similares